The Sundara Advantage

What sets Sundara apart is a rare combination of cardiovascular specialization, integrated clinical practice, advanced onsite diagnostics, a uniquely diverse patient population, and cutting-edge imaging infrastructure — including cardiac PET, nuclear medicine, and emerging theranostic capabilities — all supported by rapid startup capabilities.

Cardiovascular Focus

Large chronic cardiovascular population with an established referral network spanning Central Florida.

Integrated Care + Research

Research operations are embedded within an active clinical cardiology practice for seamless patient access.

Advanced Diagnostics Onsite

PET, nuclear imaging, echocardiography, and vascular ultrasound available directly at the site.

Diverse Population

Significant Hispanic/Latino, Medicare, and high chronic-disease-burden populations aligned with trial priorities.

Rapid Startup

72-hour feasibility turnaround and dedicated regulatory support to accelerate site activation.

Advanced Imaging & Precision Medicine Infrastructure

Onsite PET imaging capabilities enabling precise myocardial perfusion, viability, and inflammation assessment for advanced cardiovascular trials.
Specialized imaging protocols for ATTR and AL amyloidosis — a rapidly growing area of cardiovascular clinical research.
Full nuclear medicine infrastructure supporting diagnostic and therapeutic radiopharmaceutical protocols across cardiovascular and oncology-adjacent programs.

Neuroimaging capabilities supporting cardiometabolic-neurological intersection studies, including cognitive and cerebrovascular research.
Comprehensive suite including echocardiography, vascular ultrasound, and cardiac MRI-ready protocols for multi-modal imaging studies.
Positioned at the forefront of theranostic development — integrating diagnostic imaging with targeted therapeutic delivery for next-generation precision medicine trials.

How We Do It

A Deep, Diverse Patient Database

Sundara's competitive edge lies in its comprehensive, multi-source patient database encompassing a wide range of cardiovascular and cardiometabolic conditions. Enrollment is supported by patients drawn from our internal EMR, the private practices of our Principal Investigators, community outreach efforts, and hospital referrals — ensuring robust, timely subject identification for every study.

This integrated approach mitigates enrollment risk and provides sponsors with confidence in our ability to meet recruitment targets efficiently and on schedule.

Population Demographics

Sundara serves a richly diverse patient population that is highly aligned with the demographic priorities of cardiovascular and cardiometabolic clinical trials. Our population reflects the communities of Central Florida — diverse in ethnicity, age, and chronic disease burden.

Hispanic / Latino

One of the largest and most underrepresented groups in cardiovascular research

African American

Significant representation among chronic disease and cardiovascular populations

Adults with Hypertension

High chronic disease burden directly aligned with cardiovascular trial criteria

Medicare Age (65+)

Robust enrollment pool for outcomes-based and aging-population studies

Adults with Diabetes

Significant cardiometabolic overlap supporting diabetes and CKD-focused trials

Sundara Geographic Reach

Strategically located in Central Florida, Sundara serves a total impacted population of 5.2 million+ across Orange, Seminole, Osceola, Lake, and Volusia counties — providing unmatched geographic access to cardiovascular patients across the region.

Recruitment Strategy

Therapeutic Areas

Sundara employs a multi-channel recruitment model designed to maximize enrollment speed and participant diversity. Our approach draws from both internal clinical pipelines and active community engagement programs throughout Central Florida.

Recruitment Sources

Premier Cardiology EMR database mining
Cardiologist & APP referrals
Existing research participants
Community health events & health fairs
Hispanic community outreach programs
Senior centers & Medicare networks
PCP & specialist referral networks
Hospital affiliations & social media campaigns

Core Therapeutic Areas

Why Sponsors Choose Sundara

Large, pre-identified cardiovascular patient population
Embedded clinical practice model ensures continuous access
Advanced diagnostics onsite — no referrals required
Bilingual (English/Spanish) recruitment and consent capabilities
Rapid patient identification, screening, and enrollment

Sundara conducts high-quality clinical trials across a broad and expanding range of therapeutic areas — anchored in cardiovascular and cardiometabolic disease, and extending into advanced imaging, molecular medicine, and next-generation theranostic programs.

Cardiovascular Disease

CAD, Heart Failure (HFrEF/HFmrEF/HFpEF), Hypertension, Atrial Fibrillation, PVD, ASCVD

Advanced Cardiovascular Imaging

Multi-modal imaging studies including echocardiography, vascular ultrasound, and cardiac MRI-ready protocols

Brain Imaging

Neuroimaging supporting cardiometabolic-neurological intersection studies, including cognitive and cerebrovascular research

Cardiometabolic Disease

Type 2 Diabetes, Obesity, Dyslipidemia, Chronic Kidney Disease, Cardiorenal Syndrome

Lipid Disorders

Hyperlipidemia, Familial Hypercholesterolemia, Triglyceride Disorders

Nuclear Medicine

Diagnostic and therapeutic radiopharmaceutical protocols across cardiovascular and oncology-adjacent programs

Precision Medicine

Genomics, biomarker-driven protocols, and personalized therapeutic approaches integrated into trial design

Cardiac Amyloidosis

ATTR and AL amyloidosis with dedicated onsite imaging and diagnostic protocols

Advanced & Emerging Therapeutic Areas

Molecular Imaging

Targeted imaging at the molecular level to support biomarker-driven and precision medicine trials

Theranostics ★ Future Growth

Emerging integration of diagnostic imaging with targeted therapeutic delivery — Sundara is actively building infrastructure to support next-generation theranostic trials

Sponsor Experience

Sundara has partnered with globally recognized pharmaceutical sponsors across Phase I–IV cardiovascular, cardiometabolic, lipid, and vaccine programs — demonstrating the trust industry leaders place in our capabilities, patient access, and data quality.

Work With Us

Previous Sponsors Include:

Pfizer

Merck

Regeneron

Novartis

AstraZeneca

Boehringer Ingelheim

Community Outreach

Sundara and Premier Cardiology are strategically embedded within the rapidly growing Central Florida region, providing access to a large and diverse cardiovascular and cardiometabolic patient population across Orange, Seminole, Osceola, and surrounding counties.

Our community outreach model is designed to extend the reach of clinical research beyond the clinic walls — building awareness, trust, and participation among populations that are historically underrepresented in clinical trials, including Hispanic/Latino, Medicare-age, and high-burden chronic disease communities.

Our population is highly aligned with cardiovascular outcomes, obesity, diabetes, heart failure, arrhythmia, and vascular clinical research programs — making Sundara an ideal partner for sponsors seeking diverse, representative enrollment.